---
title: "Linzess (linaclotide), all indications: Drug interactions questions"
description: "Drug interactions questions on Linzess (linaclotide) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What drug interactions does Linzess have? 1 question quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/linzess/drug-interactions"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Linzess (linaclotide), all indications: Drug interactions questions

Manufacturer: AbbVie, Inc.; Ironwood Pharmaceuticals, Inc.  
Prescribing information: [Linzess](https://www.rxabbvie.com/pdf/linzess_pi.pdf)  
Indication pages: [Irritable bowel syndrome with constipation](https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation)

## Drug interactions

<a id="linzess-drug-interactions"></a>

### What drug interactions does Linzess have?

> “No drug-drug interactions are anticipated”

Source: [LINZESS: LINZESS® (linaclotide) Dosing | IBS-C, CIC & Functional constipation, captured 2026-11-14](https://www.linzesshcp.com/linzess-dosing#:~:text=No%20drug%2Ddrug%20interactions%20are%20anticipated)

> “No drug-drug interaction studies have been conducted with LINZESS. Systemic exposures of 
> drug and active metabolite are negligible following oral administration. 
>
> Linaclotide does not interact with the cytochrome P450 enzyme system based on the results of 
> in vitro studies. In addition, linaclotide does not interact with common efflux and uptake 
> transporters (including the efflux transporter P-glycoprotein (P-gp)). Based on these in vitro 
> data no drug-drug interactions through modulation of CYP enzymes or common transporters 
> are anticipated.”

Source: [LINZESS: Prescribing information, page 14, captured 2026-11-14](https://www.rxabbvie.com/pdf/linzess_pi.pdf#page=14)

## Related pages
- [Medical information: Linzess (linaclotide): All indications](https://www.evicenter.com/medical-information/linzess)
- [Indication](https://www.evicenter.com/medical-information/linzess/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/linzess/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/linzess/safety)
- [Specific populations](https://www.evicenter.com/medical-information/linzess/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/linzess/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/linzess/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/linzess/access-and-coverage)
